[{"id":"e560ec4a-8063-4c7a-880e-a6ea19e8745c","acronym":"BHARAT-1","url":"https://clinicaltrials.gov/study/NCT05607199","created_at":"2024-02-01T04:20:23.252Z","updated_at":"2024-07-02T16:35:21.461Z","phase":"Phase 1","brief_title":"A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics","source_id_and_acronym":"NCT05607199 - BHARAT-1","lead_sponsor":"Aurigene Discovery Technologies Limited","biomarkers":" IL6 • TNFA • IL1A • CCL3","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL1A • CCL3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AUR-103"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 09/16/2022","start_date":" 09/16/2022","primary_txt":" Primary completion: 09/16/2025","primary_completion_date":" 09/16/2025","study_txt":" Completion: 10/16/2026","study_completion_date":" 10/16/2026","last_update_posted":"2024-01-31"},{"id":"16375f35-57e8-4891-ab8d-34d2a7ad1e54","acronym":"","url":"https://clinicaltrials.gov/study/NCT04495894","created_at":"2021-01-18T21:35:34.159Z","updated_at":"2024-07-02T16:35:32.024Z","phase":"Phase 1","brief_title":"Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma","source_id_and_acronym":"NCT04495894","lead_sponsor":"Emory University","biomarkers":" IL6 • TNFA • CXCL8 • IL2 • IL10 • CSF2 • IL1A • IL1B","pipe":" | ","alterations":" IL10 elevation","tags":["IL6 • TNFA • CXCL8 • IL2 • IL10 • CSF2 • IL1A • IL1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IL10 elevation"],"overall_status":"Recruiting","enrollment":" Enrollment 76","initiation":"Initiation: 08/24/2020","start_date":" 08/24/2020","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 10/01/2024","study_completion_date":" 10/01/2024","last_update_posted":"2023-10-24"},{"id":"b61b36ed-ff52-451e-a650-5e97ce622140","acronym":"NL77292.056.21","url":"https://clinicaltrials.gov/study/NCT05303480","created_at":"2022-03-31T18:53:01.830Z","updated_at":"2024-07-02T16:35:57.111Z","phase":"","brief_title":"Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides","source_id_and_acronym":"NCT05303480 - NL77292.056.21","lead_sponsor":"Centre for Human Drug Research, Netherlands","biomarkers":" PD-L1 • CD8 • CXCL8 • CD4 • CCL20 • IL1A • CCL27 • IL13 • IL1R1 • IL4","pipe":"","alterations":" ","tags":["PD-L1 • CD8 • CXCL8 • CD4 • CCL20 • IL1A • CCL27 • IL13 • IL1R1 • IL4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Valchlor (mechlorethamine gel)"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 12/07/2021","start_date":" 12/07/2021","primary_txt":" Primary completion: 12/08/2022","primary_completion_date":" 12/08/2022","study_txt":" Completion: 12/08/2022","study_completion_date":" 12/08/2022","last_update_posted":"2023-01-24"},{"id":"110ea52b-e84e-4c4f-ac59-5c89e4d16963","acronym":"EPITHEM","url":"https://clinicaltrials.gov/study/NCT04576429","created_at":"2021-01-18T21:50:49.552Z","updated_at":"2024-07-02T16:36:16.766Z","phase":"","brief_title":"Immune Profiles Evolution Under Immunotherapy for Melanoma","source_id_and_acronym":"NCT04576429 - EPITHEM","lead_sponsor":"Assistance Publique - Hôpitaux de Paris","biomarkers":" VEGFA • IFNG • IL6 • TNFA • CXCL10 • IL2 • CCL20 • IL10 • CCL19 • CCL2 • GZMB • IL17A • IL1A • IFNA1 • IL1B • IL1RN • TGFA • TNFSF10 • CXCL1 • IL33","pipe":"","alterations":" ","tags":["VEGFA • IFNG • IL6 • TNFA • CXCL10 • IL2 • CCL20 • IL10 • CCL19 • CCL2 • GZMB • IL17A • IL1A • IFNA1 • IL1B • IL1RN • TGFA • TNFSF10 • CXCL1 • IL33"],"overall_status":"Recruiting","enrollment":" Enrollment 360","initiation":"Initiation: 01/27/2021","start_date":" 01/27/2021","primary_txt":" Primary completion: 01/01/2031","primary_completion_date":" 01/01/2031","study_txt":" Completion: 01/01/2031","study_completion_date":" 01/01/2031","last_update_posted":"2022-02-23"},{"id":"58983750-f972-41eb-a87b-5b3ad10f44fe","acronym":"","url":"https://clinicaltrials.gov/study/NCT03243786","created_at":"2021-01-18T16:01:33.705Z","updated_at":"2024-07-02T16:36:20.089Z","phase":"","brief_title":"Stay on Track: A Study of Exercise Effects During Radiation","source_id_and_acronym":"NCT03243786","lead_sponsor":"Medical College of Wisconsin","biomarkers":" IFNG • IL6 • TNFA • CXCL8 • IL10 • CSF2 • IL1A • IL1B • IL4 • LEP","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • CXCL8 • IL10 • CSF2 • IL1A • IL1B • IL4 • LEP"],"overall_status":"Completed","enrollment":" Enrollment 47","initiation":"Initiation: 04/12/2017","start_date":" 04/12/2017","primary_txt":" Primary completion: 09/01/2018","primary_completion_date":" 09/01/2018","study_txt":" Completion: 10/31/2018","study_completion_date":" 10/31/2018","last_update_posted":"2021-11-30"},{"id":"b9949f74-e4d6-4f59-8592-9d6c650b15e5","acronym":"","url":"https://clinicaltrials.gov/study/NCT04926467","created_at":"2021-06-15T17:53:15.026Z","updated_at":"2024-07-02T16:36:29.057Z","phase":"Phase 2","brief_title":"Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)","source_id_and_acronym":"NCT04926467","lead_sponsor":"Baylor Research Institute","biomarkers":" IL6 • IL1A • IL1B • CA 19-9","pipe":"","alterations":" ","tags":["IL6 • IL1A • IL1B • CA 19-9"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • paclitaxel • albumin-bound paclitaxel • oxaliplatin • irinotecan • Kineret (anakinra)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 06/01/2021","start_date":" 06/01/2021","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 06/01/2026","study_completion_date":" 06/01/2026","last_update_posted":"2021-06-15"},{"id":"d64ec15b-672e-4adf-91db-3ab01f2bc847","acronym":"","url":"https://clinicaltrials.gov/study/NCT03825471","created_at":"2022-06-14T05:03:57.273Z","updated_at":"2024-07-02T16:36:48.904Z","phase":"","brief_title":"Cranial Electrotherapy Stimulation on Anesthetics Consumption and Postoperative Pain","source_id_and_acronym":"NCT03825471","lead_sponsor":"Tri-Service General Hospital","biomarkers":" IL6 • TNFA • IL2 • IL10 • IL1A","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL2 • IL10 • IL1A"],"overall_status":"Unknown status","enrollment":" Enrollment 80","initiation":"Initiation: 01/14/2019","start_date":" 01/14/2019","primary_txt":" Primary completion: 12/31/2020","primary_completion_date":" 12/31/2020","study_txt":" Completion: 12/31/2020","study_completion_date":" 12/31/2020","last_update_posted":"2020-03-11"},{"id":"d6d64b89-f7f7-4bec-a903-6fffbe1ea5b6","acronym":"DISTINCTIVE","url":"https://clinicaltrials.gov/study/NCT04252456","created_at":"2021-01-18T20:39:55.170Z","updated_at":"2024-07-02T16:36:50.523Z","phase":"","brief_title":"Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status","source_id_and_acronym":"NCT04252456 - DISTINCTIVE","lead_sponsor":"Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente","biomarkers":" KDR • RAS • FLT4 • IL1A","pipe":" | ","alterations":" RAS wild-type","tags":["KDR • RAS • FLT4 • IL1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 5-fluorouracil • irinotecan • leucovorin calcium • Zaltrap (ziv-aflibercept IV)"],"overall_status":"Unknown status","enrollment":" Enrollment 150","initiation":"Initiation: 04/23/2018","start_date":" 04/23/2018","primary_txt":" Primary completion: 04/01/2020","primary_completion_date":" 04/01/2020","study_txt":" Completion: 02/01/2021","study_completion_date":" 02/01/2021","last_update_posted":"2020-02-05"},{"id":"35e608cc-539c-4ac1-a89a-c289c5e8a0c6","acronym":"","url":"https://clinicaltrials.gov/study/NCT01522404","created_at":"2021-01-18T06:24:18.792Z","updated_at":"2024-07-02T16:36:57.820Z","phase":"Phase 2","brief_title":"Effects of Atomoxetine in Mild Cognitive Impairment","source_id_and_acronym":"NCT01522404","lead_sponsor":"Emory University","biomarkers":" IL1A • APOE • CYP2D6","pipe":"","alterations":" ","tags":["IL1A • APOE • CYP2D6"],"overall_status":"Completed","enrollment":" Enrollment 39","initiation":"Initiation: 03/01/2012","start_date":" 03/01/2012","primary_txt":" Primary completion: 10/31/2017","primary_completion_date":" 10/31/2017","study_txt":" Completion: 06/30/2018","study_completion_date":" 06/30/2018","last_update_posted":"2019-07-23"},{"id":"a4052baa-f418-48f0-bc38-3c3c3e89a2e5","acronym":"","url":"https://clinicaltrials.gov/study/NCT03625635","created_at":"2022-06-12T16:56:41.706Z","updated_at":"2024-07-02T16:37:07.989Z","phase":"","brief_title":"Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment","source_id_and_acronym":"NCT03625635","lead_sponsor":"Humberto Francisco Astiazaran Garcia, PhD","biomarkers":" IFNG • IL6 • TNFA • IL2 • IL10 • IL17A • IL1A • IL1B","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • IL2 • IL10 • IL17A • IL1A • IL1B"],"overall_status":"Unknown status","enrollment":" Enrollment 34","initiation":"Initiation: 09/14/2015","start_date":" 09/14/2015","primary_txt":" Primary completion: 09/01/2018","primary_completion_date":" 09/01/2018","study_txt":" Completion: 08/01/2019","study_completion_date":" 08/01/2019","last_update_posted":"2018-08-10"}]